• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AN69透析效率,一种不太适合扩散的半合成膜。

Dialysis Efficiency of AN69, a Semisynthetic Membrane Not Well Suited for Diffusion.

作者信息

Herrera-Gutiérrez M E, Seller-Pérez G, Arias Verdu D, Jironda-Gallegos C, Martín-Velázquez M, Quesada-García G

机构信息

ICU, Carlos Haya Hospital, Carlos Haya Avenue s/n, 29010 Málaga, Spain.

Nephrology, Carlos Haya Hospital, 29010 Málaga, Spain.

出版信息

ISRN Nephrol. 2012 Dec 20;2013:185989. doi: 10.5402/2013/185989. eCollection 2013.

DOI:10.5402/2013/185989
PMID:24959535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4045434/
Abstract

AN69 membrane is not suited for diffusion, with an suggested limit at 25 mL/min dialysate flow rate. When prescribing continuous hemodialysis this threshold must be surpassed to achieve. We designed a study aimed to check if a higher dose of dialysis could be delivered efficiently with this membrane. Ten ICU patients under continuous hemodiafiltration with 1.4 m(2) AN69 membrane were included and once a day we set the monitor to exclusively 50 mL/min dialysate flow rate and 250 mL/min blood flow rate and after 15 minutes measured dialysate saturation for urea, creatinine, and β 2-microglobulin. We detected that urea saturation of dialysate was nearly complete (1.1 ± 0.09) for at least 40 hours, while creatinine saturation showed a large dispersion (0.86 ± 0.22) and did not detect any relation for these variables with time, blood flow, or anticoagulation regime. Saturation of β 2-microglobulin was low (0.34 ± 0.1) and decreased discretely with time (r (2) = 0.15, P < 0.05) and significantly with TMP increases (r (2) = 0.31, P < 0.01). In our experience AN69 membrane shows a better diffusive capability than previously acknowledged, covering efficiently the range of standard dosage for continuous therapies. Creatinine is not a good marker of the membrane diffusive capability.

摘要

AN69膜不适合用于扩散,建议的透析液流速上限为25毫升/分钟。在进行持续性血液透析时,必须超过这个阈值才能实现目标。我们设计了一项研究,旨在检查使用这种膜是否能够有效地提供更高剂量的透析。纳入了10例使用1.4平方米AN69膜进行持续性血液滤过的重症监护病房患者,每天一次,我们将监测器设置为仅50毫升/分钟的透析液流速和250毫升/分钟的血流速,15分钟后测量透析液中尿素、肌酐和β2-微球蛋白的饱和度。我们检测到,透析液中尿素饱和度在至少40小时内几乎达到完全饱和(1.1±0.09),而肌酐饱和度差异较大(0.86±0.22),且未发现这些变量与时间、血流或抗凝方案之间存在任何关系。β2-微球蛋白的饱和度较低(0.34±0.1),并随时间逐渐降低(r(2)=0.15,P<0.05),且随跨膜压升高显著降低(r(2)=0.31,P<0.01)。根据我们的经验,AN69膜的扩散能力比之前认为的更好,能够有效地覆盖持续性治疗的标准剂量范围。肌酐不是膜扩散能力的良好标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e104/4045434/e8214cf14dbb/ISRN.NEPHROLOGY2013-185989.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e104/4045434/fd6a2abf94fc/ISRN.NEPHROLOGY2013-185989.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e104/4045434/cee7f6b6c47d/ISRN.NEPHROLOGY2013-185989.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e104/4045434/e8214cf14dbb/ISRN.NEPHROLOGY2013-185989.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e104/4045434/fd6a2abf94fc/ISRN.NEPHROLOGY2013-185989.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e104/4045434/cee7f6b6c47d/ISRN.NEPHROLOGY2013-185989.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e104/4045434/e8214cf14dbb/ISRN.NEPHROLOGY2013-185989.003.jpg

相似文献

1
Dialysis Efficiency of AN69, a Semisynthetic Membrane Not Well Suited for Diffusion.AN69透析效率,一种不太适合扩散的半合成膜。
ISRN Nephrol. 2012 Dec 20;2013:185989. doi: 10.5402/2013/185989. eCollection 2013.
2
Therapeutic effects of the long-term use of PAN membrane dialyzer in hemodialysis patients: efficacy in old dialysis patients with mild PAD.长期使用PAN膜透析器对血液透析患者的治疗效果:对轻度外周动脉疾病老年透析患者的疗效
J Nippon Med Sch. 2014;81(4):221-35. doi: 10.1272/jnms.81.221.
3
Clinical evaluation of internal hemodiafiltration (iHDF): a diffusive-convective technique performed with internal filtration enhanced high-flux dialyzers.内部血液透析滤过(iHDF)的临床评估:一种采用内部过滤增强型高通量透析器进行的弥散对流技术。
Int J Artif Organs. 2004 May;27(5):414-9. doi: 10.1177/039139880402700511.
4
Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates.在不同透析液和超滤流速下进行持续肾脏替代治疗时的扩散性和对流性溶质清除率。
Am J Kidney Dis. 1999 Sep;34(3):486-92. doi: 10.1016/s0272-6386(99)70076-4.
5
On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations.在线血液透析滤过。β2微球蛋白清除显著。长期临床观察。
Nephrol Dial Transplant. 2000;15 Suppl 1:49-54. doi: 10.1093/oxfordjournals.ndt.a027964.
6
Dialysate and blood flow dependence of diffusive solute clearance during CVVHD.连续性静脉-静脉血液透析滤过期间扩散性溶质清除对透析液和血流量的依赖性
ASAIO J. 1992 Jul-Sep;38(3):M691-6. doi: 10.1097/00002480-199207000-00127.
7
Dialysis membrane-dependent removal of middle molecules during hemodiafiltration: the beta2-microglobulin/albumin relationship.血液透析滤过过程中透析膜对中分子物质的清除:β2-微球蛋白与白蛋白的关系
Clin Nephrol. 2004 Jul;62(1):21-8. doi: 10.5414/cnp62021.
8
Con-Current versus Counter-Current Dialysate Flow during CVVHD. A Comparative Study for Creatinine and Urea Removal.连续性静脉-静脉血液透析滤过中顺向与逆向透析液流动的比较研究:肌酐和尿素清除情况对比
Blood Purif. 2016;41(1-3):171-6. doi: 10.1159/000441270. Epub 2016 Jan 15.
9
Hemodiafiltration using readily available equipment.
J Dial. 1979;3(1):27-39. doi: 10.3109/08860227909064910.
10
Comparison of high-efficiency and standard haemodialysis providing equal urea clearances by partial and total dialysate quantification.通过部分和全部透析液定量比较提供相等尿素清除率的高效血液透析和标准血液透析。
Nephrol Dial Transplant. 1997 Jun;12(6):1182-6. doi: 10.1093/ndt/12.6.1182.

本文引用的文献

1
Cost of acute renal replacement therapy in the intensive care unit: results from The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) study.重症监护病房急性肾脏替代治疗的成本:来自开始和结束肾脏支持治疗(BEST Kidney)研究的结果。
Crit Care. 2010;14(2):R46. doi: 10.1186/cc8933. Epub 2010 Mar 26.
2
Intensity of continuous renal-replacement therapy in critically ill patients.危重症患者持续肾脏替代治疗的强度
N Engl J Med. 2009 Oct 22;361(17):1627-38. doi: 10.1056/NEJMoa0902413.
3
Intensity of renal support in critically ill patients with acute kidney injury.
急性肾损伤危重症患者的肾脏支持强度
N Engl J Med. 2008 Jul 3;359(1):7-20. doi: 10.1056/NEJMoa0802639. Epub 2008 May 20.
4
Dose and efficiency of renal replacement therapy: continuous renal replacement therapy versus intermittent hemodialysis versus slow extended daily dialysis.肾脏替代治疗的剂量与效率:连续性肾脏替代治疗对比间歇性血液透析对比缓慢延长每日透析
Crit Care Med. 2008 Apr;36(4 Suppl):S229-37. doi: 10.1097/CCM.0b013e318168e467.
5
Renal replacement therapy in patients with acute renal failure: a systematic review.急性肾衰竭患者的肾脏替代治疗:一项系统评价
JAMA. 2008 Feb 20;299(7):793-805. doi: 10.1001/jama.299.7.793.
6
[Use of isolated epoprostenol or associated to heparin for the maintenance of the patency of the continuous renal replacement technical circuits].[使用分离的依前列醇或联合肝素维持连续性肾脏替代技术回路的通畅]
Med Intensiva. 2006 Oct;30(7):314-21. doi: 10.1016/s0210-5691(06)74536-3.
7
[Epidemiology of acute kidney failure in Spanish ICU. Multicenter prospective study FRAMI].[西班牙重症监护病房急性肾衰竭的流行病学。多中心前瞻性研究FRAMI]
Med Intensiva. 2006 Aug-Sep;30(6):260-7. doi: 10.1016/s0210-5691(06)74522-3.
8
Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial.连续性静脉-静脉血液透析滤过与间歇性血液透析治疗多器官功能障碍综合征患者急性肾衰竭的多中心随机试验。
Lancet. 2006 Jul 29;368(9533):379-85. doi: 10.1016/S0140-6736(06)69111-3.
9
Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion.危重症患者连续性肾脏替代治疗中的溶质清除:对流与扩散
Crit Care. 2006;10(2):R67. doi: 10.1186/cc4903.
10
Acute renal failure in critically ill patients: a multinational, multicenter study.危重症患者的急性肾衰竭:一项多国多中心研究。
JAMA. 2005 Aug 17;294(7):813-8. doi: 10.1001/jama.294.7.813.